Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab
Clinical trial NCT03135171 · COMPLETED
Trial details
- NCT number
- NCT03135171
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2020-03-16
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.